Mechanisms of HSV egress
HSV 流出机制
基本信息
- 批准号:10097988
- 负责人:
- 金额:$ 19.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-04 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:Afferent NeuronsAntiviral AgentsBlindnessCapsidCell NucleusCellsComplexCrystallizationDNA VirusesDataDevelopmentDiseaseEncephalitisEpithelialEpithelial CellsEventFilamentGenesGenitalGenitaliaHerpesviridaeHerpesvirus 1ImpairmentInfectionIntegration Host FactorsInterferonsInvadedLaminsMass Spectrum AnalysisMediatingMembraneModelingMolecularMucous MembraneMultiprotein ComplexesNatureNeuronsNuclearNuclear EnvelopeNuclear Inner MembraneNuclear LaminaNuclear Outer MembraneNuclear TranslocationNucleocapsidNucleoplasmPathogenesisPathway interactionsPhosphorylationPlayProcessProductionProtein Kinase CProteinsProteomicsRegulationResearchResolutionRoleSeriesSimplexvirusSiteSourceStructureSurfaceTherapeuticTissuesUlcerVesicleViralViral ProteinsVirionVirulence FactorsVirusVirus DiseasesVirus ReplicationWorkbasecell typecellular protein p32designgene productgenetic analysishuman pathogeninsightnovel vaccinesprotein activationreactivation from latencyrecruitrecurrent infectionresponse
项目摘要
Herpes simplex virus 1 (HSV-1) is a human pathogen which infects the epithelial cells of the mucosal tissues where the virus undergoes entry, replication, assembly and egress, leading to productive infection. Following primary replication, the virus invades the sensory neurons to establish latency. Reactivation from latency occurs periodically, which is a lifelong source of virus responsible for recurrent infections. As a large DNA virus, HSV-1 assembles progeny capsids in the nucleus of infected cells. To exit, HSV-1 traverses the nucleoplasm, crosses the lamina of a dense meshwork of lamin filaments, and buds through the nuclear membranes in a two-step process known as “envelopment and de-envelopment”. Therefore, the virus drives vesiculation of the inner nuclear membrane and forms enveloped virions in the perinuclear space. Primary virions then fuse with the outer nuclear membrane to release the naked capsids for further maturation. In this process the nuclear egress complex, composed of viral proteins UL31 and UL34, plays an essential role. While UL31/UL34 orchestrates a series of events, the regulatory circuit is unclear in virus-infected cells. Accumulating evidence suggests the hypothesis that additional virus and host factors may work coordinately, which is particularly relevant to temporal or cell-type specific regulation of viral replication. This research will investigate the mechanism of HSV nuclear egress, with a focus on a virulence factor γ134.5. Firstly, genetic analysis will be performed to identify viral determinants that direct host p32/gC1qR and protein kinase C to the sites of nuclear budding. Furthermore, studies will be carried out to examine the nature of host factor recruitment. Secondly, systematic analysis will be integrated to investigate the interplay of 134.5 and the nuclear egress complex. The objective is to define the pathways that control local dissolution of nuclear lamina and capsid transit in the nucleoplasm upon virus infection. Together, these studies will provide insights into the remodeling of nuclear envelope pertinent to herpesvirus replication and maturation.
单纯疱疹病毒1(HSV-1)是感染粘膜组织的上皮细胞的人类病原体,其中病毒经历进入、复制、组装和排出,导致生产性感染。初次复制后,病毒侵入感觉神经元以建立潜伏期。潜伏期的再激活周期性发生,这是导致反复感染的病毒的终身来源。作为一种大的DNA病毒,HSV-1在感染细胞的细胞核中组装后代衣壳。为了离开,HSV-1穿过核质,穿过核纤层蛋白丝的致密网状结构的层,并在称为“增殖和去增殖”的两步过程中通过核膜出芽。因此,病毒驱动内核膜的囊泡化并在核周空间中形成有包膜的病毒体。原代病毒体与外核膜融合,释放出裸露的衣壳,进一步成熟。在这个过程中,由病毒蛋白UL 31和UL 34组成的核出口复合物起着至关重要的作用。虽然UL 31/UL 34协调了一系列事件,但在病毒感染的细胞中,调控回路尚不清楚。越来越多的证据表明,假设额外的病毒和宿主因素可能会协调工作,这是特别相关的时间或细胞类型的病毒复制的特定调节。本研究将研究HSV核出口的机制,重点是毒力因子γ134.5。首先,将进行遗传分析以鉴定将宿主p32/gC 1 qR和蛋白激酶C引导至核出芽位点的病毒决定簇。此外,还将开展研究,审查东道国因素征聘的性质。其次,将系统分析整合到调查的相互作用,134.5和核出口复杂。目的是确定控制病毒感染后核纤层的局部溶解和核质中衣壳转运的途径。总之,这些研究将提供有关疱疹病毒复制和成熟的核膜重塑的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BIN HE其他文献
BIN HE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BIN HE', 18)}}的其他基金
Imaging Epilepsy Sources with Biophysically Constrained Deep Neural Networks
使用生物物理约束的深度神经网络对癫痫源进行成像
- 批准号:
10655833 - 财政年份:2023
- 资助金额:
$ 19.99万 - 项目类别:
Electrophysiology-Compatible Wearable Transcranial Focused Ultrasound Neuromodulation Array Probes
电生理学兼容的可穿戴经颅聚焦超声神经调制阵列探头
- 批准号:
10616201 - 财政年份:2023
- 资助金额:
$ 19.99万 - 项目类别:
Characterization of in vivo neuronal and inter-neuronal responses to transcranial focused ultrasound
体内神经元和神经元间对经颅聚焦超声反应的表征
- 批准号:
10337754 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 19.99万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 19.99万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 19.99万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 19.99万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 19.99万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 19.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 19.99万 - 项目类别: